Immune Repertoire Sequencing Market By Cancer Product Type (Assay Kits, Instruments), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development And Efficacy, Infectious Diseases, Others), By End-User (Diagnostic Labs, Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Others) - Industry Size, Growth, Share And Forecast To 2026
Immune Repertoire Sequencing refers to novel approach to next generation sequencing that helps to understand and examine immune mediated diseases. The Global market for Immune Repertoire Sequencing is expected to witness a substantial growth, growing at a CAGR of approximately 8% over the forecast period of 2019-2026. Immune repertoire sequencing is among the most accurate and sensitive platform for the profiling of antigen specific information within lymphocytes. The main advantage with this technique is that it is minimally invasive in nature and requires low amount of sample. The market for Immune repertoire sequencing is primarily driven by growing prevalence of cancer, growing research in the field of immunotherapy along with growing pharmaceutical R&D expenditure.
The report on the global immune repertoire sequencing market covers segmentation analysis of application, product type and end-user. Based on application the market is sub-segmented into cancer immunotherapy, biomarker discovery, autoimmune diseases, vaccine development and efficacy, infectious diseases and others. Cancer immunotherapy is expected to dominate the application segment. Growing research funding in cancer research along with the substantial adoption of next gen sequencing to develop immune response against cancer act as the primary driver for the dominance of cancer immunotherapy in the application segment. Based on the End-User the market is segmented into diagnostics labs, biotech and pharmaceutical companies, academic & research Institute and others. The Biotech and pharmaceutical companies dominate the end user segment driven by the growing pharma R&D and growing acceptance of immune repertoire sequencing for drug and vaccine development.
Geographically North America is expected to account for the largest market share in terms of revenue for the immune repertoire sequencing market followed by Asia Pacific and Europe in 2017. Presence of prominent pharmaceutical and biotechnology companies such as Abbvie, Pfizer, Johnson and Johnson and others in the region coupled with high research and development funding by the U.S. Department of Health and Human Services are the key driver for the growth of immune repertoire sequencing market in the region. As per the official data released by NIH, the NIH has spent a total of $2.00 trillion in 2018 for research of various disease and condition including cancer, CVD, autoimmune diseases and others. However, Asia Pacific market is expected to grow at the highest rate owing to growing pharmaceutical sector and high public private investment in the biotechnology sector. The pharmaceutical market India was valued at $ 20.95 billion in 2011 that increased to $ 27.57 billion in 2016, as per India Brand Equity Foundation (IBEF). Similarly as per the health care information company IQVIA in 2017, China is the world’s second-largest national pharmaceutical market accounting for $122.6 billion in 2017
The major market players of the global immune repertoire sequencing market are Illumina Inc., Roche Holding AG, ArcherDX, Inc., CD Genomics, Atreca, Inc. and Others. The companies in the market to increase their dominance are inclined towards collaborative research for new product development. For instance, in 2017 Illumina Inc signed a partnership agreement with Bio-Rad Laboratories, Inc., the partnership is aimed at jointly develop and to launch single cell genomic sequencing solution based on the NGS workflow.
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Immune Repertoire Sequencing Market
2.1.1. Global Immune Repertoire Sequencing Market, by Product Type, 2018 (US$ Mn)
2.1.2. Global Immune Repertoire Sequencing Market, by Application, 2018 (US$ Mn)
2.1.3. Global Immune Repertoire Sequencing Market, by End-User, 2018 (US$ Mn)
2.1.4. Global Immune Repertoire Sequencing Market, by Geography, 2018 (US$ Mn)
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increasing Prevalence of Cancer
3.2.1.2. Increasing Research and Development on Immune Therapies
3.2.1.3. Growing pharmaceutical R&D expenditure
3.2.2. Market Restraints
3.2.2.1. Limitations persisting to use of immune repertoire
3.2.3. Market Opportunities
3.2.3.1. Advancements in Immune Repertoire Sequencing Research
3.2.3.2. Growing healthcare expenditure
3.2.4. Market Challenges
3.2.4.1. Non-uniform approach towards data collection and processing
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Immune Repertoire Sequencing Market, by Product Type
4.1. Overview
4.1.1. Global Immune Repertoire Sequencing Market Value Share, by Product Type, 2018 & 2026 (Value, %)
4.1.2. Global Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
4.2. Assay Kits
4.2.1. Global Immune Repertoire Sequencing Market for Assay Kits, 2019-2026 (US$ Mn)
4.2.2. Global Immune Repertoire Sequencing Market for Assay Kits, by Region 2019-2026 (US$ Mn)
4.3. Instruments
4.3.1. Global Immune Repertoire Sequencing Market for Instruments, 2019-2026 (US$ Mn)
4.3.2. Global Immune Repertoire Sequencing Market for Instruments, by Region 2019-2026 (US$ Mn)
5. Global Immune Repertoire Sequencing Market, by Application
5.1. Overview
5.1.1. Global Immune Repertoire Sequencing Market Value Share, by Application, 2018 & 2026 (Value, %)
5.1.2. Global Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
5.2. Cancer Immunotherapy
5.2.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.2.2. Global Immune Repertoire Sequencing Market for Cancer Immunotherapy, 2019-2026 (US$ Mn)
5.2.3. Global Immune Repertoire Sequencing Market for Cancer Immunotherapy, by Region 2019-2026 (US$ Mn)
5.3. Biomarker Discovery
5.3.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.3.2. Global Immune Repertoire Sequencing Market for Biomarker Discovery, 2019-2026 (US$ Mn)
5.3.3. Global Immune Repertoire Sequencing Market for Biomarker Discovery, by Region 2019-2026 (US$ Mn)
5.4. Autoimmune Diseases
5.4.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.4.2. Global Immune Repertoire Sequencing Market for Autoimmune Diseases, 2019-2026 (US$ Mn)
5.4.3. Global Immune Repertoire Sequencing Market for Autoimmune Diseases, by Region 2019-2026 (US$ Mn)
5.5. Vaccine Development and Efficacy
5.5.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.5.2. Global Immune Repertoire Sequencing Market for Vaccine Development and Efficacy 2019-2026 (US$ Mn)
5.5.3. Global Immune Repertoire Sequencing Market for Vaccine Development and Efficacy, by Region 2019-2026 (US$ Mn)
5.6. Infectious Diseases
5.6.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.6.2. Global Immune Repertoire Sequencing Market for Infectious Diseases 2019-2026 (US$ Mn)
5.6.3. Global Immune Repertoire Sequencing Market for Infectious Diseases, by Region 2019-2026 (US$ Mn)
5.7. Others
5.7.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.7.2. Global Immune Repertoire Sequencing Market for Others, 2019-2026 (US$ Mn)
5.7.3. Global Immune Repertoire Sequencing Market for Others, by Region 2019-2026 (US$ Mn)
6. Global Immune Repertoire Sequencing Market, by End-User
6.1. Overview
6.1.1. Global Immune Repertoire Sequencing Market Value Share, by End-User, 2018 & 2026 (Value, %)
6.1.2. Global Immune Repertoire Sequencing Market, by End-User, 2019-2026 (US$ Mn)
6.2. Diagnostic Labs
6.2.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
6.2.2. Global Immune Repertoire Sequencing Market for Diagnostic Labs, 2019-2026 (US$ Mn)
6.2.3. Global Immune Repertoire Sequencing Market for Diagnostic Labs, by Region 2019-2026 (US$ Mn)
6.3. Biotechnology and Pharmaceutical Companies
6.3.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
6.3.2. Global Immune Repertoire Sequencing Market for Biotechnology and Pharmaceutical Companies, 2019-2026 (US$ Mn)
6.3.3. Global Immune Repertoire Sequencing Market for Biotechnology and Pharmaceutical Companies, by Region 2019-2026 (US$ Mn)
6.4. Academic and Research Institutes
6.4.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
6.4.2. Global Immune Repertoire Sequencing Market for Academic and Research Institutes, 2019-2026 (US$ Mn)
6.4.3. Global Immune Repertoire Sequencing Market for Academic and Research Institutes, by Region 2019-2026 (US$ Mn)
6.5. Others
6.5.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
6.5.2. Global Immune Repertoire Sequencing Market for Others, 2019-2026 (US$ Mn)
6.5.3. Global Immune Repertoire Sequencing Market for Others, by Region 2019-2026 (US$ Mn)
7. North America Immune Repertoire Sequencing Market Analysis
7.1. Overview
7.1.1. North America Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
7.1.2. North America Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
7.1.3. North America Immune Repertoire Sequencing Market, by End-User, 2019-2026 (US$ Mn)
7.1.4. North America Immune Repertoire Sequencing Market, by Country, 2019-2026 (US$ Mn)
7.1.4.1. United States
7.1.4.1.1. United States Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
7.1.4.2. Canada
7.1.4.2.1. Canada Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
8. Europe Immune Repertoire Sequencing Market Analysis
8.1. Overview
8.1.1. Europe Immune Repertoire Sequencing Market, by Cancer Product Type, 2019-2026 (US$ Mn)
8.1.2. Europe Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
8.1.3. Europe Immune Repertoire Sequencing Market, by End-User, 2019-2026 (US$ Mn)
8.1.4. Europe Immune Repertoire Sequencing Market, by Country/Region, 2019-2026 (US$ Mn)
8.1.4.1. UK
8.1.4.1.1. UK Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
8.1.4.2. Germany
8.1.4.2.1. Germany Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
8.1.4.3. France
8.1.4.3.1. France Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
8.1.4.4. Rest of Europe
8.1.4.4.1. Rest of Europe Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
9. Asia Pacific Immune Repertoire Sequencing Market Analysis
9.1. Overview
9.1.1. Asia Pacific Immune Repertoire Sequencing Market, by Cancer Product Type, 2019-2026 (US$ Mn)
9.1.2. Asia Pacific Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
9.1.3. Asia Pacific Immune Repertoire Sequencing Market, by End-User, 2019-2026 (US$ Mn)
9.1.4. Asia Pacific Immune Repertoire Sequencing Market, by Country/Region, 2019-2026 (US$ Mn)
9.1.4.1. China
9.1.4.1.1. China Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
9.1.4.2. India
9.1.4.2.1. India Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
9.1.4.3. Japan
9.1.4.3.1. Japan Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
9.1.4.4. Rest of Asia Pacific
9.1.4.4.1. Rest of Asia Pacific Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
10. Rest of the World Immune Repertoire Sequencing Market Analysis
10.1. Overview
10.1.1. Rest of the World Immune Repertoire Sequencing Market, by Cancer Product Type, 2019-2026 (US$ Mn)
10.1.2. Rest of the World Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
10.1.3. Rest of the World Immune Repertoire Sequencing Market, by End-User, 2019-2026 (US$ Mn)
10.1.4. Rest of the World Immune Repertoire Sequencing Market, by Country/Region, 2019 – 2026 (US$ Mn)
10.1.4.1. Latin America
10.1.4.1.1. Latin America Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
10.1.4.2. MENA
10.1.4.2.1. MENA Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
11. Company Profiles
11.1. Illumina Inc. (USA)
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.3. Key Strategies
11.1.4. Key Conclusion
11.2. Roche Holding AG (Switzerland)
11.2.1. Company Overview
11.2.2. Product Portfolio
11.2.3. Key Strategies
11.2.4. Key Conclusion
11.3. ArcherDX, Inc. (USA)
11.3.1. Company Overview
11.3.2. Product Portfolio
11.3.3. Key Strategies
11.3.4. Key Conclusion
11.4. CD Genomics (USA)
11.4.1. Company Overview
11.4.2. Product Portfolio
11.4.3. Key Strategies
11.4.4. Key Conclusion
11.5. Atreca, Inc. (USA)
11.5.1. Company Overview
11.5.2. Product Portfolio
11.5.3. Key Strategies
11.5.4. Key Conclusion
11.6. Adaptive Biotechnologies (USA)
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Key Strategies
11.6.4. Key Conclusion
11.7. Agilent Technologies, Inc. (USA)
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Key Strategies
11.7.4. Key Conclusion
11.8. Takara Bio, Inc. (Japan)
11.8.1. Company Overview
11.8.2. Product Portfolio
11.8.3. Key Strategies
11.8.4. Key Conclusion
11.9. Qiagen N.V. (Germany)
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Key Strategies
11.9.4. Key Conclusion
11.10. Amgen Inc (U.S.)
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Key Strategies
11.10.4. Key Conclusion
1. Global Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
2. Global Immune Repertoire Sequencing Market for Assay Kit, by Region 2019-2026 (US$ Mn)
3. Global Immune Repertoire Sequencing Market for Instruments, by Region 2019-2026 (US$ Mn)
4. Global Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
5. Global Immune Repertoire Sequencing Market for Cancer Immunotherapy, by Region 2019-2026 (US$ Mn)
6. Global Immune Repertoire Sequencing Market for Biomarker Discovery, by Region 2019-2026 (US$ Mn)
7. Global Immune Repertoire Sequencing Market for Autoimmune Diseases, by Region 2019-2026 (US$ Mn)
8. Global Immune Repertoire Sequencing Market for Vaccine Development and Efficacy, by Region 2019-2026 (US$ Mn)
9. Global Immune Repertoire Sequencing Market for Infectious Diseases, by Region 2019-2026 (US$ Mn)
10. Global Immune Repertoire Sequencing Market for Others, by Region 2019-2026 (US$ Mn)
11. Global Immune Repertoire Sequencing Market, by End User, 2019-2026 (US$ Mn)
12. Global Immune Repertoire Sequencing Market for Diagnostic Labs, by Region 2019-2026 (US$ Mn)
13. Global Immune Repertoire Sequencing Market for Biotechnology and Pharmaceutical Companies, by Region 2019-2026 (US$ Mn)
14. Global Immune Repertoire Sequencing Market for Academic and Research Institutes, by Region 2019-2026 (US$ Mn)
15. Global Immune Repertoire Sequencing Market for Others, by Region 2019-2026 (US$ Mn)
16. Global Immune Repertoire Sequencing Market, by Geography, 2019-2026 (US$ Mn)
17. North America Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
18. North America Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
19. North America Immune Repertoire Sequencing Market, by End User, 2019-2026 (US$ Mn)
20. North America Immune Repertoire Sequencing Market, by Country, 2019-2026 (US$ Mn)
21. Europe Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
22. Europe Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
23. Europe Immune Repertoire Sequencing Market, by End User, 2019-2026 (US$ Mn)
24. Europe Immune Repertoire Sequencing Market, by Country/Region, 2019-2026 (US$ Mn)
25. Asia Pacific Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
26. Asia Pacific Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
27. Asia Pacific Immune Repertoire Sequencing Market, by End User, 2019-2026 (US$ Mn)
28. Asia Pacific Immune Repertoire Sequencing Market, by Country/Region, 2019-2026 (US$ Mn)
29. Rest of the World Immune Repertoire Sequencing Market, by Product Type, 2019-2026 (US$ Mn)
30. Rest of the World Immune Repertoire Sequencing Market, by Application, 2019-2026 (US$ Mn)
31. Rest of the World Immune Repertoire Sequencing Market, by End User, 2019-2026 (US$ Mn)
32. Rest of the World Immune Repertoire Sequencing Market, by Country/Region, 2019 – 2026 (US$ Mn)
1. Global Immune Repertoire Sequencing Market, by Type, 2018 (US$ Mn)
2. Global Immune Repertoire Sequencing Market, by Application, 2018 (US$ Mn)
3. Global Immune Repertoire Sequencing Market, by End User, 2018 (US$ Mn)
4. Global Immune Repertoire Sequencing Market, by Geography, 2018 (US$ Mn)
5. Global Immune Repertoire Sequencing Market Value Share, by Product Type, 2018 & 2026 (Value, %)
6. Global Immune Repertoire Sequencing Market for Assay Kit, 2019-2026 (US$ Mn)
7. Global Immune Repertoire Sequencing Market for Instruments, 2019-2026 (US$ Mn)
8. Global Immune Repertoire Sequencing Market for Services, 2019-2026 (US$ Mn)
9. Global Immune Repertoire Sequencing Market Value Share, by Application, 2018 & 2026 (Value, %)
10. Global Immune Repertoire Sequencing Market for Cancer Immunotherapy, 2019-2026 (US$ Mn)
11. Global Immune Repertoire Sequencing Market for Biomarker Discovery, 2019-2026 (US$ Mn)
12. Global Immune Repertoire Sequencing Market for Autoimmune Diseases, 2019-2026 (US$ Mn)
13. Global Immune Repertoire Sequencing Market for Vaccine Development and Efficacy, 2019-2026 (US$ Mn)
14. Global Immune Repertoire Sequencing Market for Infectious Diseases, 2019-2026 (US$ Mn)
15. Global Immune Repertoire Sequencing Market for Others, 2019-2026 (US$ Mn)
16. Global Immune Repertoire Sequencing Market Value Share, by End User, 2018 & 2026 (Value, %)
17. Global Immune Repertoire Sequencing Market for Diagnostic Labs, 2019-2026 (US$ Mn)
18. Global Immune Repertoire Sequencing Market for Biotechnology and Pharmaceutical Companies, 2019-2026 (US$ Mn)
19. Global Immune Repertoire Sequencing Market for Academic and Research Institutes, by Region 2019-2026 (US$ Mn)
20. Global Immune Repertoire Sequencing Market for Others, 2019-2026 (US$ Mn)
21. United States Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
22. Canada Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
23. UK Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
24. Germany Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
25. France Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
26. Rest of Europe Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
27. China Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
28. India Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
29. Japan Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
30. Rest of Asia Pacific Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
31. Latin America Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
32. MENA Immune Repertoire Sequencing Market 2019 – 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)